Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of Vedolizumab in Ulcerative Colitis
NCT01177228Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2007
- Primary completion
- Jun 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of vedolizumab in ulcerative colitis (UC), sponsored by Millennium Pharmaceuticals. Started May 2007; status: completed.
02
Drugs
vedolizumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01177228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177228.